Showing 1 - 18 of 18

1

Research Progress on the Structure and Function, Immune Escape Mechanism, Antiviral Drug Development Methods, and Clinical Use of SARS-CoV-2 Mpro
Jiayi Ren ; Zhengfu Zhang ; Yi Xia ; et al.
Molecules ; Volume 30 ; Issue 2 ; Pages: 351

agris SARS-CoV-2 main protease (M pro ) structure and function immune escape drug development methods
Academic journal
2

Pharmacological Neuroenhancement: Current Aspects of Categorization, Epidemiology, Pharmacology, Drug Development, Ethics, and Future Perspectives.
Daubner, Johanna ; Arshaad, Muhammad Imran ; Henseler, Christina ; et al.
Neural plasticity 2021, 1 - 27 (2021). doi:10.1155/2021/8823383

DE info:eu-repo/classificat... Affect: drug effects Affect: physiology Central Nervous System S... Central Nervous System S...
Academic journal
3

Verifying and Validating Quantitative Systems Pharmacology and In Silico Models in Drug Development: Current Needs, Gaps, and Challenges.
Musuamba, Flora T ; Bursi, Roberta ; Manolis, Efthymios ; et al.
CPT: Pharmacometrics and Systems Pharmacology, 9 (4), 195-197 (2020-04)

Computer Simulation/stan... Drug Development/methods Humans Models Biological Pharmacology
Academic journal
4

A feature enrichment and feature selection approach to improve prediction of drug target interaction and ligand-based virtual screening
Dai, Weixing (author.) ; Guo, Dianjing (thesis advisor.) ; Chinese University of Hong Kong Graduate School. Division of Life Sciences. (degree granting institution.)

Drug development Ligands High throughput screenin... Drug Development--method... High-Throughput Screenin...
Academic journal
5

Smart cancer nanomedicine
van der Meel, Roy ; Sulheim, Einar ; Shi, Y. ; et al.
van der Meel, R, Sulheim, E, Shi, Y, Kiessling, F, Mulder, W & Lammers, T 2019, 'Smart cancer nanomedicine', Nature Nanotechnology, vol. 14, no. 11, pp. 1007–1017. https://doi.org/10.1038/s41565-019-0567-y

Animals Antineoplastic Agents/ad... Biomarkers Tumor/analysis Drug Carriers/chemistry Drug Delivery Systems/me...
Academic journal
6

Factor XI Inhibition fulfilling the optimal expectations for ideal anticoagulation
Székely, Orsolya ; Borgi, Marco ; Lip, Gregory Y H
Székely, O, Borgi, M & Lip, G Y H 2019, 'Factor XI Inhibition fulfilling the optimal expectations for ideal anticoagulation', Expert Opinion on Emerging Drugs, vol. 24, no. 1, pp. 55-61. https://doi.org/10.1080/14728214.2019.1591368

Anticoagulation coagulation cascade drug discovery factor XI haemostasis intrinsic pathway
Academic journal
7

Receptor and Molecular Targets for the Development of Novel Opioid and Non-Opioid Analgesic Therapies
Chen, Rosalyn ; Coppes, OJ Michael ; Urman, Richard D
School of Medicine Faculty Publications

Analgesics Non-Narcotic/administrat... Opioid/administration &... Animals Drug Delivery Systems/me... Drug Development/methods
Academic journal
8

Patient-focused drug development methods for benefit-risk assessments:A case study using discrete choice experiment for antiepileptic drugs
Holmes, Emily A.F. ; Plumpton, Catrin ; Baker, Gus A. ; et al.
Holmes , E A F , Plumpton , C , Baker , G A , Jacoby , A , Ring , A , Williamson , P , Marson , A & Hughes , D A 2019 , ' Patient-focused drug development methods for benefit-risk assessments : A case study using discrete choice experiment for antiepileptic drugs ' , Clinical Pharmacology and Therapeutics , vol. 105 , no. 3 , pp. 672-683 . https://doi.org/10.1002/cpt.1231

Adolescent Adult Aged Anticonvulsants/administ... Drug Development/methods Female
Academic journal
9

Emerging drugs for treating the acute respiratory distress syndrome
Shaw, Timothy D ; McAuley, Daniel F ; O'Kane, Cecilia M
Shaw, T D, McAuley, D F & O'Kane, C M 2019, 'Emerging drugs for treating the acute respiratory distress syndrome', Expert opinion on emerging drugs, vol. 24, no. 1, pp. 29-41. https://doi.org/10.1080/14728214.2019.1591369

Animals Clinical Trials as Topic... Cost of Illness Drug Development/methods Drug Evaluation Preclinical/methods
Academic journal
10

IGF-1 as a Drug for Preterm Infants : A Step-Wise Clinical Development
Hellstrom, Ann ; Ley, David ; Hallberg, Boubou ; et al.
Current Pharmaceutical Design; 23(38), pp 5964-5970 (2017) ; ISSN: 1381-6128

Pharmacology and Toxicol... Drug Development/methods Humans Infant Newborn Infusions
Academic journal
12

Bioequivalence studies in drug development methods and application.
Newlands, Amy
Statistical Methods in Medical Research. Feb2009, Vol. 18 Issue 1, p112-113. 2p.

BIOEQUIVALENCE Studies i... HAUSCHKE, Dieter PIGEOT, Iris STEINIJANS, Volker DRUG development NONFICTION
Review
13

Bioequivalence Studies In Drug Development: Methods and Applications.
BRADSTREET, Thomas E.
Journal of the American Statistical Association. Sep2008, Vol. 103 Issue 483, p1319-1320. 2p.

BIOEQUIVALENCE Studies i... HAUSCHKE, Dieter STEINIJANS, Volker PIGEOT, Iris THERAPEUTIC equivalency... NONFICTION
Review
14

A Review of: "Bioequivalence Studies in Drug Development: Methods and Applications, by D. Hauschke, V. Steinijans and I. Pigeot".
Patterson, Scott
Journal of Biopharmaceutical Statistics. Feb2008, Vol. 18 Issue 1, p208-209. 2p.

BIOEQUIVALENCE Studies i... HAUSCHKE, D. STEINIJANS, V. PIGEOT, I. DRUG development NONFICTION
Review
15

Bioequivalence Studies in Drug Development, Methods and Applications by D. HAUSCHKE, V. STEINIJANS, and I. PIGEOT.
Shein-Chung Chow
Biometrics. Sep2007, Vol. 63 Issue 3, p969-970. 2p.

BIOEQUIVALENCE Studies i... HAUSCHKE, D. STEINIJANS, V. PIGEOT, I. THERAPEUTIC equivalency... NONFICTION
Review
16

Bioequivalence Studies in Drug Development: Methods and Applications by Dieter Hauschke, Volker Steinijans, Iris Pigeot.
Mathew, Thomas
International Statistical Review. Aug2007, Vol. 75 Issue 2, p272-273. 2p.

BIOEQUIVALENCE Studies i... HAUSCHKE, Dieter STEINIJANS, Volker PIGEOT, Iris THERAPEUTIC equivalency... NONFICTION
Review
17

This result is not available to guest users.

18

This result is not available to guest users.


Filter